GLUE logo
GLUE NASDAQ US

Monte Rosa Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2021
$17.09
▼ $-0.08 (-0.47%)
Vol 1.2M
7
Quality Score
fail
Mkt Cap
$1.0B
P/E
48.7
ROE
8.3%
Margin
11.5%
D/E
0.00
Beta
1.59
52W
$4–$19

Wall Street Consensus

15 analysts · Apr 2026
5
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
93.3%
Buy Rating

Price Chart

Similar Stocks

VIR
Vir Biotechnology Inc
$838.9M
IOVA
Iovance Biotherapeutics Inc
$1.1B
PGEN
Precigen Inc
$1.5B
BCAX
Bicara Therapeutics Inc
$922.0M
OLMA
Olema Pharmaceuticals Inc
$2.0B
ZBIO
Zenas Biopharma Inc
$2.3B
TSHA
Taysha Gene Therapies Inc
$1.5B
NVAX
Novavax Inc
P/E 3.2
$1.1B

Earnings

Beat rate: 80.0%
Next Report May 06, 2026
EPS Estimate: $-0.42
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.42 — —
Dec 2025 $-0.36 $-0.56 $-0.20
Sep 2025 $-0.38 $-0.33 +$0.05
Jun 2025 $-0.39 $-0.15 +$0.24

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 10.0% 10.0% 10.0% 10.0% 8.3% 8.3%
P/E (TTM) 11.48 11.32 19.17 32.84 49.06 48.75
Net Margin -53.0% 13.6% 13.6% 13.6% 11.5% 11.5%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 7.16 7.16 7.16 7.16 6.54 6.54

Key Ratios

ROA (TTM)
5.1%
P/S (TTM)
5.62
P/B
1.9
EPS (TTM)
$0.25
CF/Share
$-2.58
52W High
$19.17
52W Low
$3.50
$3.50 52-Week Range $19.17

How does GLUE compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

GLUE AAPG ABEO ABOS ABP

GLUE valuation vs Biotechnology peers

P/E ratio
48.8
▲ 160% above peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
5.6
▼ 56% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.9
▼ 22% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

GLUE profitability vs Biotechnology peers

ROE
8.3%
▲ 112% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
11.5%
▲ 104% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
5.1%
▲ 111% above peers (-46.7%)
vs Peers
vs Industry
Top tier

GLUE financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.5
▲ 47% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
1.6
▲ 64% above peers (1.0)
vs Peers
vs Industry
More volatile

GLUE fundamentals radar

GLUE Peer median Industry

GLUE profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

GLUE vs peers: key metrics

Latest News

No related news yet